Researchers Dr. Marc Therrien at the Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal, and Dr. Frank Sicheri, at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto, have discovered a new target that may be instrumental in the development of new, more effective cancer therapies.
High Hopes for a New Kind of Gene
In a beautifully written article in the July 2009 issue of Smithsonian magazine writer Sylvia Pagan Westphal describes the research of Dr. Carlo Croce, head of Ohio State University's Human Cancer Genetics Program.
A single cell in a 1-millimeter nematode worm is providing valuable new clues into cancer's deadliest behavior -- its ability to put down roots in new tissues after spreading throughout the body.
Biologist Phong Tran who is Associate Professor of Cell and Developmental Biology at the University of Pennsylvania School of Medicine Associate has discovered a new mechanism in cell division which has implications for understanding aberrant chromosome's role in cancer according to the Penn Study.
